Kwon Solutions launches MediTrans, a specialized Translation service platform for the pharmaceutical and biotech Industry

Kwon Solutions (CEO Kwon Kie), a company specializing in custom biomedical translation and research services, announced the launch of MediTrans (https://www.meditrans.co.kr), a medical translation platform.

Since its establishment in 2020, Kwon Solutions has collaborated with various global companies and CROs, providing professional translation services for clinical trial documents, research papers, and more in the fields of biotechnology, chemistry, and biology. With the launch of MediTrans, the company aims to offer more differentiated, high-quality services to its domestic clients.

A representative from Kwon Solutions stated that MediTrans was established with the goal of improving translation service quality in the pharmaceutical and biotech industries. They expect that the MediTrans platform, which connects domestic and international professional translators with pharmaceutical and biotech companies, will enable highly skilled translators, fluent in various languages and cultures, to effectively respond to diverse translation requests from clients, including clinical trial documents, medical papers, and marketing materials.

In particular, MediTrans not only provides translation services but also offers support for overseas marketing and market research for domestic companies looking to expand internationally in the pharmaceutical and biotech sectors. It is expected that this service will significantly enhance the global competitiveness of domestic companies.

The overseas marketing support and market research services are available tailored to the needs and business characteristics of clients and can be requested through consultations with the MediTrans customer center.